The DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.
Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease
Open accessAbstract
Triglycerides represent 1 component of a heterogeneous pool of triglyceride-rich lipoproteins (TGRLs). The reliance on triglycerides or TGRLs as cardiovascular disease (CVD) risk biomarkers prompted investigations into therapies that lower plasma triglycerides as a means to reduce CVD events. Genetic studies identified TGRL components and pathways involved in their synthesis and metabolism. We advocate that only a subset of genetic mechanisms regulating TGRLs contribute to the risk of CVD events. This "omic" approach recently resulted in new targets for reducing CVD events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Fibrates or fibric acid derivatives exert their lipidmodifying effects by activating the peroxisome proliferator-activated receptor (PPAR)-a, a nuclear receptor that increases expression of LPL, apoAI, and other lipid-related genes”
From The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk (2019) · cites this paper as [13]
In the citing paper
“Specifically, TRLs have been implicated in pro-inflammatory signaling pathways, impairment of insulin sensitivity and upregulation of factors promoting thrombosis.22,23”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationWiller (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Self-citationGenome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Self-citationMajor lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Flagged first, then by citations
1 of the 160 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
Dysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Self-citationSandesara, P. B., Virani, S. S., Fazio, S., & Shapiro, M. D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00184 · Cited by 608
A Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 529
Hypertriglyceridaemia and risk of coronary artery disease
Reiner, Ž. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.31 · Cited by 390
Hypertriglyceridemia and atherosclerosis
Peng, J., Luo, F., Ruan, G., Peng, R., & Li, X. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0625-0 · Cited by 268
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Toth, P. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s104369 · Cited by 237
Management of hypertriglyceridemia
Simha, V. (2020) · BMJ · doi:10.1136/bmj.m3109 · Cited by 230
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
Backes, J., Anzalone, D., Hilleman, D., & Catini, J. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0286-4 · Cited by 195
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
Dhindsa, D. S., Sandesara, P. B., Shapiro, M. D., & Wong, N. D. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00088 · Cited by 208
The dawn of a new era of targeted lipid-lowering therapies
Tokgözoğlu, L., & Libby, P. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab841 · Cited by 171
Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.035 · Cited by 175
Lu, X., Peloso, G. M., Liu, D. J., Wu, Y., Zhang, H., Zhou, W., Li, J., Tang, C. S.-M., Dorajoo, R., Li, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3978 · Cited by 160
Self-citationPlasma lipidomics reveals potential lipid markers of major depressive disorder
Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9768-5 · Cited by 148
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology
Rosenson, R. S., Brewer, H. B., Barter, P. J., Björkegren, J., Chapman, M. J., Gaudet, D., Kim, D. S., Niesor, E. J., Rye, K., Sacks, F. M., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.115 · Cited by 149
Self-citationMechanisms and Treatment of Dyslipidemia in Diabetes
Bahiru, E. M., Hsiao, R., Philipson, D. J., & Watson, K. E. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01455-w · Cited by 145
McGuinn, L. A., Schneider, A. E., McGarrah, R. W., Ward-Caviness, C. K., Neas, L., Di, Q., Schwartz, J. D., Hauser, E. R., Kraus, W. E., Cascio, W. E., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.11.001 · Cited by 140
Rosenson, R. S., Gaudet, D., Ballantyne, C. M., Baum, S. J., Bergeron, J., Kershaw, E. E., Moriarty, P. M., Rubba, P., Whitcomb, D. C., Banerjee, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02222-w · Cited by 140
Self-citationLawler, P. R., Kotrri, G., Koh, M., Goodman, S. G., Farkouh, M. E., Lee, D. S., Austin, P. C., Udell, J. A., & Ko, D. T. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz767 · Cited by 113
Huang, Q., Liu, Z., Wei, M., Huang, Q. Y., Feng, J., Liu, Z., & Xia, J. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01839-y · Cited by 120
Lu, Y., Cui, X., Zhang, L., Wang, X., Xu, Y., Qin, Z., Liu, G., Wang, Q., Tian, K., Lim, K. S., et al. (2022) · Aging and Disease · doi:10.14336/ad.2021.0929 · Cited by 117
Wulff, A. B., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310473 · Cited by 113
Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
Hiyoshi, T., Fujiwara, M., & Zemin, Y. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160164 · Cited by 112
Orringer, C. E., Jacobson, T. A., & Maki, K. C. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2019.10.014 · Cited by 103
Bartlett, J., Predazzi, I. M., Williams, S. M., Bush, W. S., Kim, Y., Havas, S., Toth, P. P., Fazio, S., & Miller, M. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002436 · Cited by 96
Karlson, B. W., Palmer, M. K., Nicholls, S. J., Lundman, P., & Barter, P. J. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.02.011 · Cited by 105
HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease
Kontush, A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.07.005 · Cited by 93
You, A. Y. F., Bergholt, M. S., St‐Pierre, J., Kit‐Anan, W., Pence, I. J., Chester, A. H., Yacoub, M. H., Bertazzo, S., & Stevens, M. M. (2017) · Science Advances · doi:10.1126/sciadv.1701156 · Cited by 88
Ma, F., Darabi, M., Tubeuf, E., Canicio, A., Lhomme, M., Frisdal, É., Lebreton, S., Mathéron, L., Rached, F. H., Ponnaiah, M., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319894114 · Cited by 88
Qamar, A., Khetarpal, S. A., Khera, A. V., Qasim, A., Rader, D. J., & Reilly, M. P. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305415 · Cited by 79
Identifying an optimal cutpoint for the diagnosis of hypertriglyceridemia in the nonfasting state
White, K. T., Moorthy, M. V., Akinkuolie, A. O., Demler, O., Ridker, P. M., Cook, N. R., & Mora, S. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241752 · Cited by 74
The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases
Bernardi, S., Marcuzzi, A., Piscianz, E., Tommasini, A., & Fabris, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124058 · Cited by 71
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
Zhang, B., Yin, F., Qiao, Y.-N., & Guo, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.909151 · Cited by 83
Xie, W., Liu, J., Wang, W., Wang, M., Qi, Y., Zhao, F., Sun, J., Liu, J., Li, Y., & Zhao, D. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.103 · Cited by 73
Lawler, P. R., Akinkuolie, A. O., Harada, P. H. N., Glynn, R. J., Chasman, D. I., Ridker, P. M., & Mora, S. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007402 · Cited by 69
Huang, H., Guo, Y., Liu, Z., Zeng, Y., Chen, Y., & Xu, C. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac283 · Cited by 65
Lipoproteins in chronic kidney disease: from bench to bedside
Speer, T., Ridker, P. M., von Eckardstein, A., Schunk, S. J., & Fliser, D. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1050 · Cited by 67
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Packard, C. J., Pirillo, A., Tsimikas, S., Ference, B. A., & Catapano, A. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad177 · Cited by 65
Rodríguez‐Carrio, J., Alpéri, M., López, P., López‐Mejías, R., Alonso-Castro, S., Abal, F., Ballina‐García, F. J., González-Gay, M. Á., & Suárez, A. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.05.009 · Cited by 60
Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., et al. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190507110519 · Cited by 61
Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins
Khetarpal, S. A., Vitali, C., Levin, M. G., Klarin, D. M., Park, J., Pampana, A., Millar, J. S., Kuwano, T., Dhavamani, S., Subbaiah, P. V., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009802 · Cited by 61
Alexopoulos, A., Qamar, A., Hutchins, K., Crowley, M. J., Batch, B. C., & Guyton, J. R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1136-3 · Cited by 62
Mendelian randomization to assess causal effects of blood lipids on coronary heart disease
Burgess, S., & Harshfield, E. L. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000230 · Cited by 58
Hypertriglyceridemia and Cardiovascular Diseases: Revisited
Han, S. H., Nicholls, S. J., Sakuma, I., Zhao, D. H., & Koh, K. K. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.2.135 · Cited by 60
Triglycerides and ASCVD risk reduction: recent insights and future directions
Hussain, A., Ballantyne, C. M., Saeed, A., & Virani, S. S. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00846-8 · Cited by 57
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism
Minicocci, I., Tikka, A., Poggiogalle, E., Metso, J., Montali, A., Ceci, F., Labbadia, G., Fontana, M., Di Costanzo, A., Maranghi, M., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p066183 · Cited by 56
The Effect of Blood Lipids on the Left Ventricle
Aung, N., Sanghvi, M. M., Piechnik, S. K., Neubauer, S., Munroe, P. B., & Petersen, S. E. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.583 · Cited by 53
High-density lipoproteins (HDL): Novel function and therapeutic applications
Darabi, M., & Kontush, A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159058 · Cited by 52
Basu, D., & Bornfeldt, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00504 · Cited by 51
Si, S., Hou, L., Chen, X., Li, W., Liu, X., Liu, C., Li, Y., Yuan, T., Li, J., Wang, B., et al. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20200305 · Cited by 49
Plin5 Bidirectionally Regulates Lipid Metabolism in Oxidative Tissues
Zhang, X., Xu, W., Rui, X., Wang, Z. Q., Zhang, X., Wang, P., Peng, K., Li, M., Li, J., Tan, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4594956 · Cited by 43
Bashir, B., Schofield, J., Downie, P., France, M., Ashcroft, D. M., Wright, A. K., Romeo, S., Gouni-Berthold, I., Maan, A., Durrington, P. N., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1389106 · Cited by 40
Yang, J., Chen, L., Ding, J., Zhang, J., Fan, Z., Yang, C., Yu, Q., & Yang, J. (2015) · Gene · doi:10.1016/j.gene.2015.12.037 · Cited by 40
Association of remnant cholesterol with depression among US adults
Wang, Y., & Shen, R. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04770-4 · Cited by 39
Strategies to Overcome Residual Risk During Statins Era
Cho, K. I., Yu, J., Hayashi, T., Han, S. H., & Koh, K. K. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0624 · Cited by 39
MOGAT2: A New Therapeutic Target for Metabolic Syndrome
Yang, M., & Nickels, J. T. (2015) · Diseases · doi:10.3390/diseases3030176 · Cited by 38
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia
Nurmohamed, N. S., Dallinga‐Thie, G. M., & Stroes, E. S. G. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1768848 · Cited by 42
Campanella, A., Iacovazzi, P. A., Misciagna, G., Bonfiglio, C., Mirizzi, A., Franco, I., Bianco, A., Sorino, P., Caruso, M. G., Cisternino, A. M., et al. (2020) · Nutrients · doi:10.3390/nu12061674 · Cited by 38
Wojczynski, M. K., Parnell, L. D., Pollin, T. I., Lai, C., Feitosa, M. F., O’Connell, J. R., Wood, A. C., Gibson, Q., Aslibekyan, S. W., Ryan, K. A., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.001 · Cited by 39
Efficacy and safety of the PCSK9 inhibitor evolocumab in patients with mixed hyperlipidemia
Rosenson, R. S., Jacobson, T. A., Preiss, D., Djedjos, C. S., Dent, R., Bridges, I., & Miller, M. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6666-1 · Cited by 36
Self-citationClinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies
Malick, W. A., Waksman, O., Do, R., Köenig, W., Pradhan, A. D., Stroes, E. S. G., & Rosenson, R. S. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.034 · Cited by 38
Self-citationChan, D. C., Watts, G. F., Somaratne, R. M., Wasserman, S. M., Scott, R. C., & Barrett, P. H. R. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310882 · Cited by 39
Free radicals in health and disease.
Hollán, S. R. (1995) · PubMed · Cited by 36
Gabani, M. H., Shapiro, M. D., & Toth, P. P. (2023) · European Cardiology Review · doi:10.15420/ecr.2023.16 · Cited by 40
MicroRNA-192* impairs adipocyte triglyceride storage
Mysore, R., Zhou, Y., Sädevirta, S., Savolainen-Peltonen, H. M., Haridas, P. A. N., Soronen, J., Leivonen, M., Sarin, A., Fischer‐Posovszky, P., Wabitsch, M., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.12.019 · Cited by 34
Ambrosy, A. P., Yang, J., Sung, S. H., Allen, A. R., Fitzpatrick, J. K., Rana, J. S., Wagner, J., Philip, S., Abrahamson, D., Granowitz, C., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020377 · Cited by 32
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects
Mijares, A. H., Ascaso, J. F., Blasco, M., Brea, Á., Díaz, Á., Mantilla, T., Pedro‐Botet, J., Pintó, X., & Millán, J. (2019) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2019.02.002 · Cited by 31
Cao, Y., Zhang, H., Jin, J., Liu, H., Zhang, Y., Xu, R., Gao, Y., Guo, Y., Zhu, C., Hua, Q., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000746 · Cited by 31
Multitrait GWAS to connect disease variants and biological mechanisms
Julienne, H., Laville, V., McCaw, Z. R., He, Z., Guillemot, V., Lasry, C., Ziyatdinov, A., Nerin, C., Vaysse, A., Lechat, P., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009713 · Cited by 35
Contribution of Remnant Cholesterol to Coronary Atherosclerosis
Ohmura, H. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed205 · Cited by 31
Xiao, Z., Lin, Z., Xu, L., Xu, W., Huang, H., Wang, Y., Cao, S., Xie, Z., Liao, W., Liao, Y., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad297 · Cited by 30
Chapman, M. J., Packard, C. J., Björnson, E., Ginsberg, H. N., & Borén, J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120529 · Cited by 36
Wang, J., Qin, Z. H., Wang, Z., Shi, D., Liu, Y., Zhao, Y., Yang, L., Cheng, W.-J., & Zhou, Y.-J. (2018) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2018.02.011 · Cited by 30
Kinzer, A. B., Shamburek, R. D., Lightbourne, M., Muniyappa, R., & Brown, R. J. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00103 · Cited by 30
Taskinen, M., Björnson, E., Andersson, L. K., Kahri, J., Porthan, K., Matikainen, N., Söderlund, S., Pietiläinen, K. H., Hakkarainen, A., Lundbom, N. M. I., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.12.003 · Cited by 31
Taskinen, M., Björnson, E., Kahri, J., Söderlund, S., Matikainen, N., Porthan, K., Ainola, M., Hakkarainen, A., Lundbom, N. M. I., Fermanelli, V., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315446 · Cited by 31
Understanding Hypertriglyceridemia: Integrating Genetic Insights
Alves, M., Laranjeira, F., & Correia‐da‐Silva, G. (2024) · Genes · doi:10.3390/genes15020190 · Cited by 35
Nakamura, T., Uematsu, M., Yoshizaki, T., Kobayashi, T., Watanabe, Y., & Kugiyama, K. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.08.006 · Cited by 30
Drexel, H., Tamargo, J. L., Kaski, J. C., Lewis, B. S., Saely, C. H., Fraunberger, P., Dobrev, D., Komiyama, M., PLATTNER, T., Agewall, S., et al. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad044 · Cited by 32
Bas-Prior, J. M. D., Crescenti, A., Arola‐Arnal, A., Oms‐Oliu, G., Arola, L., & Caimari, A. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.015 · Cited by 30
Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care
Hartz, J. C., de Ferranti, S. D., & Gidding, S. S. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00079 · Cited by 29
Blood lipid markers are associated with hippocampal viscoelastic properties and memory in humans
Sanjana, F., Delgorio, P. L., Hiscox, L. V., DeConne, T. M., Hobson, J. C., Cohen, M. L., Johnson, C. L., & Martens, C. R. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20968032 · Cited by 28
RNA-based therapy in the management of lipid disorders: a review
Blom, D. J., Marais, A. D., Moodley, R., van der Merwe, N., van Tonder, A., & Raal, F. J. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01649-3 · Cited by 29
Yang, H. J., Xiao, L., & Xu, D. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07001-0 · Cited by 26
Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease
Li, X., Li, Z.-F., & Wu, N. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25985 · Cited by 27
Aneni, E. C., Osondu, C. U., Cruz, J. D. L., Martin, S. S., Blaha, M. J., Younus, A., Feldman, T., Agatston, A. S., Veledar, E., & Nasir, K. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.40741 · Cited by 25
The role of Krüppel-like factor 14 in the pathogenesis of atherosclerosis
Xie, W., Li, L., Zheng, X., Yin, W., & Tang, C. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.011 · Cited by 25
Nahmias, A., Stahel, P., Tian, L., Xiao, C., & Lewis, G. F. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316311 · Cited by 23
Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C
Davidson, M. H. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx741 · Cited by 24
Self-citationUpdate on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
Catapano, A. L., & Pirillo, A. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s67551 · Cited by 23
Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez‐Martínez, P., Mora, S., Bilianou, H. I., Panotopoulos, G., Katsiki, N., Ooi, T. C., López‐Miranda, J., et al. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190503123911 · Cited by 23
Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management
Brown, W. V., Goldberg, I., Duell, B., & Gaudet, D. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.02.018 · Cited by 21
Self-citationVargas‐Vázquez, A., Fermín‐Martínez, C. A., Antonio‐Villa, N. E., Fernández‐Chirino, L., Ramírez‐García, D., Dávila-López, G., Díaz-Sánchez, J. P., Aguilar-Salinas, C. A., Seiglie, J. A., & Bello‐Chavolla, O. Y. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117508 · Cited by 21
Raatz, S. K., Johnson, L. K., Rosenberger, T. A., & Picklo, M. J. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.06.011 · Cited by 22
Maki, K. C., Bobotas, G., Dicklin, M. R., Huebner, M., & Keane, W. F. (2017) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2016.10.010 · Cited by 20
Hypertriglyceridemia and Atherosclerotic Carotid Artery Stenosis
Miura, Y., & Suzuki, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416224 · Cited by 21
The future of n-3 polyunsaturated fatty acid therapy
Davidson, M. H., & Benes, L. B. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000353 · Cited by 18
Self-citationNovel therapies for severe dyslipidemia originating from human genetics
Gaudet, D. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000281 · Cited by 18
Self-citationQin, Z. H., Zheng, F.-W., Zeng, C., Zhou, K., Geng, Y., Wang, J., Li, Y., Ji, Q., & Zhou, Y.-J. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.213575 · Cited by 18
Gómez-Delgado, F., Alcala-Diaz, J. F., Leon‐Acuña, A., López-Moreno, J., Delgado‐Lista, J., Gomez‐Marin, B., Roncero‐Ramos, I., Yubero‐Serrano, E. M., Rangel-Zúñiga, O. A., Vals‐Delgado, C., et al. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13146 · Cited by 18
Metadata
- Authors
- Rosenson, R. S., Davidson, M. H., Hirsh, B. J., Kathiresan, S., & Gaudet, D.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Chicago (US)
- Mount Sinai Hospital (US)
- Harvard University (US)
- Université de Montréal (CA)
- Corresponding author
- Rosenson, Robert S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 64
- Issue
- 23
- Pages
- 2525-2540
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2005157832
- Cited by
- 260
- References
- 160
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 12 · 2023: 26 · 2022: 27 · 2021: 21 · 2020: 28 · 2019: 23 · 2018: 21 · 2017: 19 · 2016: 26 · 2015: 15
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Regeneron Pharmaceuticals
- Kowa Company
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- triglyceride-rich lipoproteins, atherosclerotic cardiovascular disease, triglycerides, genetic risk factors, causality, cardiovascular risk markers, triglyceride-lowering therapy, lipoprotein metabolism, omics, cardiovascular disease prevention
- MeSH terms
- Cardiovascular Diseases, Fasting, Humans, Inflammation, Intestinal Mucosa, Lipoproteins, Liver, Triglycerides, Genetic Variation, Hypertriglyceridemia, Fatty Acids, Omega-3, Sequence Analysis, DNA, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Postprandial Period, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
